Skip to main content
Clinical Trials/NL-OMON50456
NL-OMON50456
Completed
Not Applicable

The background of the reduced cerebral blood flow in Duchenne muscular dystrophy - DMDPF - Duchenne muscular dystrophy cerebral perfusion study

eids Universitair Medisch Centrum0 sites27 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
duchenne muscular dystrophy
Sponsor
eids Universitair Medisch Centrum
Enrollment
27
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 30, 2020
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Age over 10 years (DMD) or 12 years (healthy)
  • \* Ambulant
  • For patients only:
  • \- a mutation in the DMD gene that affects both Dp427 and Dp140

Exclusion Criteria

  • \* No informed consent
  • \* Medical history of CV disease, diabetes mellitus, neurological disease (other
  • \* History of recurrent syncope
  • \* Joint contractures preventing the use of the HUT
  • \* Contraindication to MRI exposure (\*vragenlijst MRI onderzoek\*)
  • \* Inability to lie supine for at least 45 minutes

Outcomes

Primary Outcomes

Not specified

Similar Trials